X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (203) 203
male (169) 169
middle aged (157) 157
female (125) 125
risk factors (120) 120
aged (107) 107
cardiac & cardiovascular systems (75) 75
adult (73) 73
cardiovascular disease (73) 73
medicine, general & internal (52) 52
mortality (51) 51
prospective studies (46) 46
abridged index medicus (45) 45
cardiovascular diseases (41) 41
risk (35) 35
prevention (34) 34
cardiovascular diseases - prevention & control (32) 32
follow-up studies (32) 32
health aspects (31) 31
myocardial-infarction (31) 31
epidemiology (30) 30
treatment outcome (30) 30
double-blind method (29) 29
hypertension (29) 29
research (29) 29
blood pressure (28) 28
cardiovascular diseases - mortality (28) 28
myocardial infarction (28) 28
stroke (27) 27
diabetes (26) 26
peripheral vascular disease (26) 26
clinical medicine (25) 25
coronary-heart-disease (25) 25
health risk assessment (25) 25
heart attacks (25) 25
klinisk medicin (25) 25
prognosis (25) 25
coronary heart disease (24) 24
risk-factors (24) 24
cardiovascular (23) 23
cholesterol (23) 23
medical and health sciences (22) 22
medical research (22) 22
medicin och hälsovetenskap (22) 22
analysis (21) 21
angiotensin-converting enzyme inhibitors - therapeutic use (21) 21
canada (21) 21
care and treatment (21) 21
cohort studies (21) 21
risk assessment (21) 21
studies (21) 21
cardiovascular-disease (20) 20
clinical trials (20) 20
disease (20) 20
drug therapy (20) 20
quebec - epidemiology (20) 20
cardiac and cardiovascular systems (18) 18
cardiovascular diseases - epidemiology (18) 18
kardiologi (18) 18
time factors (18) 18
blood-pressure (17) 17
electrocardiography (17) 17
men (17) 17
prevalence (17) 17
association (16) 16
atherosclerosis (16) 16
body mass index (16) 16
metaanalysis (16) 16
proportional hazards models (16) 16
cholesterol - blood (15) 15
insulin (15) 15
myocardial ischemia - blood (15) 15
population (15) 15
public, environmental & occupational health (15) 15
triglycerides - blood (15) 15
women (15) 15
cardiology (14) 14
cholesterol, ldl - blood (14) 14
coronary-artery disease (14) 14
diabetes mellitus (14) 14
heart diseases (14) 14
incidence (14) 14
inflammation (14) 14
ramipril - therapeutic use (14) 14
angina (13) 13
biomarkers - blood (13) 13
drug therapy, combination (13) 13
myocardial infarction - epidemiology (13) 13
myocardial infarction - mortality (13) 13
plasma (13) 13
severity of illness index (13) 13
apolipoproteins b - blood (12) 12
c-reactive protein (12) 12
cardiovascular diseases - etiology (12) 12
cholesterol, hdl - blood (12) 12
endocrinology & metabolism (12) 12
health (12) 12
internal medicine (12) 12
management (12) 12
myocardial ischemia - etiology (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
by Dehghan, Mahshid and Mente, Andrew and Zhang, Xiaohe and Swaminathan, Sumathi and Li, Wei and Mohan, Viswanathan and Iqbal, Romaina and Kumar, Rajesh and Wentzel-Viljoen, Edelweiss and Rosengren, Annika and Amma, Leela Itty and Avezum, Alvaro and Chifamba, Jephat and Diaz, Rafael and Khatib, Rasha and Lear, Scott and Lopez-Jaramillo, Patricio and Liu, Xiaoyun and Gupta, Rajeev and Mohammadifard, Noushin and Gao, Nan and Oguz, Aytekin and Ramli, Anis Safura and Seron, Pamela and Sun, Yi and Szuba, Andrzej and Tsolekile, Lungiswa and Wielgosz, Andreas and Yusuf, Rita and Hussein Yusufali, Afzal and Teo, Koon K and Rangarajan, Sumathy and Dagenais, Gilles and Bangdiwala, Shrikant I and Islam, Shofiqul and Anand, Sonia S and Yusuf, Salim and Diaz, R and Orlandini, A and Linetsky, B and Toscanelli, S and Casaccia, G and Cuneo, JM Maini and Rahman, O and Yusuf, R and Azad, AK and Rabbani, KA and Cherry, HM and Mannan, A and Hassan, I and Talukdar, AT and Tooheen, RB and Khan, MU and Sintaha, M and Choudhury, T and Haque, R and Parvin, S and Avezum, A and Oliveira, GB and Marcilio, CS and Mattos, AC and Teo, K and Yusuf, S and Dejesus, J and Agapay, D and Tongana, T and Solano, R and Kay, I and Trottier, S and Rimac, J and Elsheikh, W and Heldman, L and Ramezani, E and Dagenais, G and Poirier, P and Turbide, G and Auger, D and De Bluts, A LeBlanc and Proulx, MC and Cayer, M and Bonneville, N and Lear, S and Gasevic, D and Corber, E and de Jong, V and Vukmirovich, I and Wielgosz, A and Fodor, G and Pipe, A and Shane, A and Lanas, F and Seron, P and Martinez, S and Valdebenito, A and Oliveros, M and Wei, Li and Lisheng, Liu and Chunming, Chen and Xingyu, Wang and Wenhua, Zhao and ... and Prospective Urban Rural Epidemiology (PURE) study investigators and PURE Study Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10107, pp. 2050 - 2062
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10013, pp. 61 - 69
Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 465 - 475
Journal Article
by Miller, Victoria and Mente, Andrew and Dehghan, Mahshid and Rangarajan, Sumathy and Zhang, Xiaohe and Swaminathan, Sumathi and Dagenais, Gilles and Gupta, Rajeev and Mohan, Viswanathan and Lear, Scott and Bangdiwala, Shrikant I and Schutte, Aletta E and Wentzel-Viljoen, Edelweiss and Avezum, Alvaro and Altuntas, Yuksel and Yusoff, Khalid and Ismail, Noorhassim and Peer, Nasheeta and Chifamba, Jephat and Diaz, Rafael and Rahman, Omar and Mohammadifard, Noushin and Lana, Fernando and Zatonska, Katarzyna and Wielgosz, Andreas and Yusufali, Afzalhussein and Iqbal, Romaina and Lopez-Jaramillo, Patricio and Khatib, Rasha and Rosengren, Annika and Kutty, V Raman and Li, Wei and Liu, Jiankang and Liu, Xiaoyun and Yin, Lu and Teo, Koon and Anand, Sonia and Yusuf, Salim and Diaz, R and Orlandini, A and Linetsky, B and Toscanelli, S and Casaccia, G and Cuneo, JM Maini and Rahman, O and Yusuf, R and Azad, AK and Rabbani, KA and Cherry, HM and Mannan, A and Hassan, I and Talukdar, AT and Tooheen, RB and Khan, MU and Sintaha, M and Choudhury, T and Haque, R and Parvin, S and Avezum, A and Oliveira, GB and Marcilio, CS and Mattos, AC and Teo, K and Yusuf, S and Dejesus, J and Agapay, D and Tongana, T and Solano, R and Kay, I and Trottier, S and Rimac, J and Elsheikh, W and Heldman, L and Ramezani, E and Dagenais, G and Poirier, P and Turbide, G and Auger, D and De Bluts, A LeBlanc and Proulx, MC and Cayer, M and Bonneville, N and Lear, S and Gasevic, D and Corber, E and de Jong, V and Vukmirovich, I and Wielgosz, A and Fodor, G and Pipe, A and Shane, A and Lanas, F and Seron, P and Martinez, S and Valdebenito, A and Oliveros, M and Wei, Li and Lisheng, Liu and Chunming, Chen and Xingyu, Wang and ... and Prospective Urban Rural Epidemiology (PURE) study investigators and PURE Study Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10107, pp. 2037 - 2049
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 9, pp. 818 - 827
Journal Article